ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Clinical Evaluation of Lung Transplantation for End-Stage Idiopathic Pulmonary Fibrosis Patients with Lung Cancer

J. Zhang, D. Liu, J. Chen

Lung Transplant Center, Wuxi People's Hospital, Wuxi, China

Meeting: 2020 American Transplant Congress

Abstract number: C-301

Keywords: Idiopathic pulmonary fibrosis, Lung transplantation

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session C: Lung: All Topics

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Long Term Survival After Single Versus Double Lung Transplantation in Patients With Pulmonary Fibrosis in the Modern Era of the Lung Allocation Score
  • The Impact of High-Risk Lung Donors on the Survival of Lung Recipients With Interstitial Pulmonary Fibrosis

*Purpose: The treatment of patients with end-stage idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) is a difficult task, and it remains questionable whether LC should be treated. Lung transplantation is an effective treatment for IPF. However, little knowledge indicates the effectiveness of the treatment for IPF-LC. The purpose of this study was to retrospectively evaluate the safety and clinical outcomes of lung transplantation for patients with advanced IPF-LC .

*Methods: A total of eight patients with advanced IPF-LC were enrolled in this retrospective study. The diagnosis of IPF-LC is based on pathological confirmation. Preoperative evaluation mainly includes high-resolution computed tomography of the chest (HRCT), arterial blood gas analysis, pulmonary function test, 6-minute walk test, cardiac echocardiography, skull CT, abdominal CT and positron emission tomography and computed tomography.

*Results: Of these 8 patients,7 were over 60 years old, and 6 had a history of smoking. Coughing in 7 cases, spitting in 5 cases, and all the cases had dyspnea. There were 3 cases of squamous cell carcinoma, 3 cases of adenocarcinoma, 1 case of small cell lung cancer, and 1 case of carcinoid. 4 patients received single lung transplants and 4 received double lung transplants. There were no obvious intraoperative complications, and 7 patients needed intraoperative extracorporeal membrane oxygenation (ECMO) support. Two cases were severely infected, one died within 30 days after operation. Another one died of severe arrhythmia on the 4th post-operation day. The one-year survival rate after transplantation is 75%. So far there have been no signs of tumor recurrence found.

*Conclusions: After strict preoperative assessment of lung transplantation, early lung cancer with end-stage IPF can be treated with lung transplantation. However, strict screening must be performed, and patients must be informed of the prognosis and the possibility of tumor regeneration.

 border=

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Zhang J, Liu D, Chen J. Clinical Evaluation of Lung Transplantation for End-Stage Idiopathic Pulmonary Fibrosis Patients with Lung Cancer [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/clinical-evaluation-of-lung-transplantation-for-end-stage-idiopathic-pulmonary-fibrosis-patients-with-lung-cancer/. Accessed March 2, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Enhanced Recovery after Surgery Protocols in Kidney Transplantation: Time to Change Practice?
  • Efficacy of Filgrastim in Solid Organ Transplant Recipients
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • #16789 (not found)
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.